Sr. Principal DeltaV Automation Engineer – Biotechnology

Scorpion Therapeutics; Richmond (VA); On-site; USD 140,000 - 190,000; Full time

Job summary

Scorpion Therapeutics in Richmond, VA seeks a Senior Principal Automation Engineer to lead the DeltaV DCS platform design, delivery, and startup at Lilly's monoclonal antibody facility.

You will collaborate with engineering, A&E firms, and system integrators; develop requirements, manage testing and qualification; support GMP operations post-startup; and help build site procedures and safety culture.

Qualifications

• Bachelor's in engineering or related field.
• 5+ years in Process Automation with DeltaV experience.
• 5+ years in manufacturing support.
• Authorization to work in the U.S. (no visa sponsorship).

Responsibilities

• Oversee automation system design and collaborate with engineering, A&E firms, and system integrators.
• Develop requirements, manage software testing and qualification.
• Support GMP operations post-startup.
• Develop site procedures, team capabilities, and safety culture.

Skills

Process Automation

Manufacturing Support

Collaboration with teams

Education

Bachelor's in Engineering

Tools

DeltaV

Job description

Role

Senior Principal Automation Engineer leading the design, delivery, and startup of DeltaV DCS platform for Lilly's new monoclonal antibody manufacturing facility in Richmond, VA.

Responsibilities

• oversee automation system design, collaborate with engineering, A&E firms, and system integrators;
• develop requirements, manage software testing and qualification;
• support GMP operations post-startup;
• develop site procedures, team capabilities, and safety culture.

Requirements

• Bachelor’s in engineering or related field;
• 5+ years in Process Automation with DeltaV experience;
• 5+ years in manufacturing support;
• authorization to work in the U.S. (no visa sponsorship).

High-Value

• biotech manufacturing;
• monoclonal antibodies;
• GMP compliance;
• DeltaV platform;
• process instrumentation;
• system integration;
• collaboration with corporate automation team;
• international/domestic travel (<20%);
• site startup (2029-2030).

Work Setup

site-based with integration into corporate teams.